ARPA-H Peer-reviewed
ARPA-H Commits $144 Million to the First Clinical Trials Designed to Extend Healthspan
The U.S. government's ARPA-H launches the PROSPR program: $144M over five years to identify early aging biomarkers and run the first clinical trials explicitly aimed at extending healthy lifespan.